Postmortem Diagnosis of Invasive Disseminated Aspergillosis After Tongue Piercing

Stefano Tambuzzi1, Guendalina Gentile, Salvatore Andreola

  • 1From the Laboratorio di Istopatologia Forense e Microbiologia Medico Legale-Sezione di Medicina Legale e delle Assicurazioni-Dipartimento di Scienze Biomediche per la Salute-Università degli Studi di Milano Milano, Italy.

Insights

A young man died from invasive disseminated aspergillosis, a severe fungal infection, following a tongue piercing. Autopsy revealed Aspergillus fumigatus, suggesting the piercing as a potential trigger for the fatal condition.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Forensic Pathology

Background:

  • Severe invasive fungal infections, particularly those caused by Aspergillus species, present diagnostic challenges and poor prognoses.
  • Nonspecific symptoms in severe infections can complicate clinical diagnosis, underscoring the importance of postmortem investigations.

Observation:

  • A case report of a previously healthy young man who died of septic shock three weeks after tongue piercing.
  • Autopsy revealed disseminated abscesses and granulomatous foci with central necrosis in multiple organs.
  • Histological and molecular identification confirmed Aspergillus fumigatus in all examined organs, including the tongue.

Findings:

  • Diagnosis of pseudomembranous invasive tracheobronchial aspergillosis and fatal invasive disseminated aspergillosis.
  • The presence of Aspergillus fumigatus hyphae in the tongue suggested a potential inoculation site.
  • The findings strongly implicated tongue piercing as the triggering event for the disseminated fungal infection.

Implications:

  • Highlights the potential risks associated with body piercings in relation to invasive fungal infections.
  • Emphasizes the need for thorough postmortem examinations to determine the etiology of unexplained fatal conditions.
  • Suggests a possible route of fungal dissemination through practices like tongue piercing, particularly with immunocompromised or susceptible individuals.